NAA10 Antikörper (AA 135-167)
-
- Target Alle NAA10 (ARD1A) Antikörper anzeigen
- NAA10 (ARD1A) (ARD1 Homolog, N-Acetyltransferase (ARD1A))
-
Bindungsspezifität
- AA 135-167
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser NAA10 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF)
- Homologie
- B, M
- Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogen
- This NAA10 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 135-167 amino acids from the Central region of human NAA10.
- Klon
- RB54653
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product ARD1A Primärantikörper
-
-
- Applikationshinweise
- IF: 1:25. WB: 1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Haltbarkeit
- 6 months
-
- Target
- NAA10 (ARD1A) (ARD1 Homolog, N-Acetyltransferase (ARD1A))
- Andere Bezeichnung
- NAA10 (ARD1A Produkte)
- Hintergrund
- Catalytic subunit of the N-terminal acetyltransferase A (NatA) complex which displays alpha (N-terminal) acetyltransferase activity. The NAT activity may be important for vascular, hematopoietic and neuronal growth and development. Without NAA15, displays epsilon (internal) acetyltransferase activity towards HIF1A, thereby promoting its degradation. Represses MYLK kinase activity by acetylation, and thus represses tumor cell migration. Acetylates, and stabilizes TSC2, thereby repressing mTOR activity and suppressing cancer development.
- Molekulargewicht
- 26459
- UniProt
- P41227
-